Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer

Immunofluorescent microscopy images of colorectal cancer tissues showing tumor cells and surrounding stroma including immune cells. Credit: Mayo Clinic ROCHESTER, Minn. — A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn’t been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, the team identified specific proteins — fibronectin and smooth muscle actin — within colorectal cancer tissues that are associated with resistance to immunotherapy treatment. Immunotherapy…

See also  Call for consideration of consequences of health disparity incentives in future value-based payment models
Total
0
Share
Need Help?